Immunosuppressive agents for treating IgA nephropathy

• Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial

  2023 The Lancet article Medicine Renal Diseases and Glomerulopathies Open access

  334

  citations
• Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy

  2022 JAMA article Medicine Renal Diseases and Glomerulopathies Open access cited by 1 patent

  360

  citations
• A Core Outcome Set for Trials in Glomerular Disease : A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder Workshops

  2022 RWTH Publications (RWTH Aachen) article Social Sciences Delphi Technique in Research

  11

  citations
• A Core Outcome Set for Trials in Glomerular Disease

  2021 Clinical Journal of the American Society of Nephrology article Social Sciences Delphi Technique in Research Open access

  16

  citations
• Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease

  2021 Kidney International article Social Sciences Delphi Technique in Research Open access

  12

  citations
• The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics

  2021 American Journal of Nephrology article Medicine Renal Diseases and Glomerulopathies Open access

  32

  citations
• Identifying Outcomes Important to Patients with Glomerular Disease and Their Caregivers

  2020 Clinical Journal of the American Society of Nephrology article Medicine Dialysis and Renal Disease Management Open access

  100

  citations

7 results